Wetherby Asset Management Inc Abbott Laboratories Transaction History

Wetherby Asset Management Inc

$2.13 Billion
Q3 2024

A detailed history of Wetherby Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Wetherby Asset Management Inc holds 57,392 shares of ABT stock, worth $6.59 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

57,392

Previous 58,285 1.53%

Holding current value

$6.59 Million

Previous $6.06 Million 8.04%

% of portfolio

0.31%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $89,362 - $105,490	-893 Reduced 1.53%	57,392 $6.54 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $1.04 Million - $1.16 Million	-10,284 Reduced 15.0%	58,285 $6.06 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $204,911 - $226,316	1,871 Added 2.81%	68,569 $7.79 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $367,434 - $449,769	4,074 Added 6.51%	66,698 $7.34 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $1.09 Million - $1.31 Million	-11,435 Reduced 15.44%	62,624 $6.07 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $1.86 Million - $2.07 Million	18,437 Added 33.15%	74,059 $8.07 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $385,890 - $454,215	-3,984 Reduced 6.68%	55,622 $5.63 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $457,333 - $536,522	-4,811 Reduced 7.47%	59,606 $6.55 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $877,226 - $1.02 Million	9,066 Added 16.38%	64,417 $6.23 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $749,908 - $906,399	7,347 Added 15.3%	55,351 $6.01 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $22,689 - $27,668	199 Added 0.42%	48,004 $5.68 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $235,334 - $288,154	2,037 Added 4.45%	47,805 $6.73 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $30,098 - $33,297	258 Added 0.57%	45,768 $5.41 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $133,401 - $157,032	1,261 Added 2.85%	45,510 $5.28 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $8,598 - $10,130	-79 Reduced 0.18%	44,249 $5.3 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $73,080 - $79,636	-696 Reduced 1.55%	44,328 $4.85 Million
Q3 2020 Dec 16, 2020	SELL	$91.64 - $111.29 $90,540 - $109,954	-988 Reduced 2.15%	45,024 $4.9 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $248,069 - $301,262	2,707 Added 6.25%	46,012 $5.01 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $60,337 - $77,224	788 Added 1.85%	43,305 $3.96 Million
Q1 2020 May 06, 2020	BUY	$62.82 - $91.86 $156,547 - $228,915	2,492 Added 6.23%	42,517 $3.36 Million
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $26,693 - $29,716	-340 Reduced 0.84%	40,025 $3.48 Million
Q3 2019 Oct 31, 2019	BUY	$81.84 - $88.74 $242,901 - $263,380	2,968 Added 7.94%	40,365 $3.38 Million
Q2 2019 Jul 25, 2019	SELL	$72.88 - $85.0 $212,299 - $247,605	-2,913 Reduced 7.23%	37,397 $3.15 Million
Q1 2019 May 09, 2019	BUY	$66.22 - $80.06 $17,349 - $20,975	262 Added 0.65%	40,310 $3.22 Million
Q4 2018 Jan 30, 2019	SELL	$65.56 - $74.27 $21,307 - $24,137	-325 Reduced 0.8%	40,048 $2.9 Million
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $58,985 - $71,159	970 Added 2.46%	40,373 $2.96 Million
Q2 2018 Jul 24, 2018	BUY	$57.57 - $63.54 $27,000 - $29,800	469 Added 1.2%	39,403 $2.4 Million
Q1 2018 May 04, 2018	BUY	$56.27 - $63.62 $26,053 - $29,456	463 Added 1.2%	38,934 $2.33 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $33,388 - $35,746	622 Added 1.64%	38,471 $2.2 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $1.82 Million - $2.03 Million	37,849	37,849 $2.02 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Abbott Laboratories Transaction History